The pan-Canadian Pharmaceutical Alliance (pCPA), consisting of participating federal, provincial, and territorial government public drug plans and the Canadian Generic Pharmaceutical Association (CGPA) have successfully reached an agreement on a renewed three-year pricing initiative for generic medicines that will help public drug plans continue to control their costs.

The Canadian Generic Pharmaceutical Association (CGPA) today launched an advertising campaign, created by leading advertising and design firm, Key Gordon Communications Inc, to highlight the cost savings Canadians see from using generic medicines — and the savings that could be realized if more generic medications were used.

Nanos poll finds 87 percent of Ontarians believe government should prioritize policies to strengthen domestic generic pharmaceutical industry.

The Canadian Generic Pharmaceutical Association (CGPA) is pleased to announce the unanimous election of Mr. Ray Shelley, Senior Vice President, Commercial Operations – Canada and Rest of World Markets at Apotex Inc., as Chair of CGPA.